Avandaryl is a combination of two diabetes medicines that are used to control blood sugar levels in people with type 2 diabetes. The medication works by helping your body use its natural insulin better and by causing the pancreas to produce more insulin. It comes in a tablet form that is usually taken once a day. As with any medication, there are potential side effects, such as headaches, low blood sugar, and fluid retention.
In September 2010, the U.S. Food and Drug Administration (FDA) announced that it would be severely restricting the use of rosiglitazone, one of the active ingredients in Avandaryl, due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who cannot control their diabetes on other medications (or those who are already taking the medication and doing well) will be able to take Avandaryl.
Avandaryl® (rosiglitazone and glimepiride) is a prescription medication that is used to treat type 2 diabetes (also known as non-insulin-dependent diabetes or adult-onset diabetes). The drug is a combination of two different diabetes medications: rosiglitazone maleate (Avandia®) and glimepiride (Amaryl®).
Avandaryl is manufactured by GlaxoSmithKline.